Corporate News Eli Lilly in charts: Mounjaro, Zepbound, Verzenio, and Jardiance power Q2 performance by Contributor since / Followers 3 months ago Tags: LLY Continue Reading Previous Intel in focus as Mizuho downgrades on continued headwinds; Gelsinger buys sharesNext Nvidia-backed Recursion to acquire Exscientia in all-stock deal Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ
